Journals in Immunology

21-30 of 87 results in All results

Current Opinion in Immunology

ISSN: 0952-7915
5 Year impact factor: 7
Impact factor: 7

Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed. In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications. Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. Current Opinion in Immunology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow. Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal. Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience. Division of the subject into sections The subject of Immunology is divided into 8 themed sections and 2 special sections, each of which is reviewed once a year. Innate immunity Tumour immunology Lymphocyte development and activation Antigen processing Vaccines Allergy and hypersensitivity Host pathogens Autoimmunity Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected. The Editorial Board provides support to the Editors and the Section Editors with their comments and suggestions on names and topics. Review articles in Current Opinion in Immunology are by invitation only. Review ArticlesAuthors write short review articles in which they present recent developments in their subject, emphasizing the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous two years. Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments. This successful format has made Current Opinion in Immunology one of the most highly regarded and highly cited review journals in the field.

Current Research in Immunology

ISSN: 2590-2555

Current Research in Immunology (CRIMMU) is an international peer-reviewed open access journal publishing original papers, short communications, and reviews that cover all aspects of molecular and cellular immunology. It is a companion to the highly regarded review journal Current Opinion in Immunology and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow. Current Research in Immunology topics covered include (but are not restricted to): Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunology. Mechanisms of induction, regulation and termination of innate and adaptive immunity. Development of the immune system. Intercellular communication, cooperation and regulation. Cell trafficking and dynamics. Intracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, inflammasome activation, etc). Effector mechanisms of the cells and molecules of the immune system. Structural analysis. "Omics" studies and bioinformatics. Vaccines, biotechnology and therapeutic manipulation of the immune system(therapeutic antibodies, cytokines, cellular therapies, etc). Virology and viral immunology. Studies on the human immune system as well as other model species (mice, rats, etc) are welcome. Topics which may be considered for the journal only if the following requirements are met: Studies that describe correlations between disease and genetic polymorphisms and include novel mechanistic findings underlying the associations Clinical or veterinary studies correlating disease and measurements of a molecule, cell type or other diagnostic markers and give novel mechanistic insights. Studies describing pharmacological agents and provide significant novelty on the mechanisms of action or immunological pathway targeted by the agent. Current Research in Immunology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal. Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous. Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience. Ethics in Publishing: General Statement The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to: https://www.elsevier.com/conflictsofinterest

Cytokine & Growth Factor Reviews

ISSN: 1359-6101
5 Year impact factor: 10.8
Impact factor: 13

Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Cytokine: X

ISSN: 2590-1532

Cytokine: X is being discontinued as of February 2023. If you are interested in submitting your paper to a journal, please consider: Cytokine Current Research in Immunology We would like to express our sincere thanks to the authors, reviewers and editorial board who contributed to the journal over the past years. Published papers will remain available on ScienceDirect at Cytokine: X. ------- Cytokine: X is the open access companion journal of Cytokine and has the same aims and scope and peer-review process. Cytokine: X offers authors with high-quality research who want to publish in a gold open access journal the opportunity to make their work immediately, permanently, and freely accessible. Cytokine: X authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright. Please check the APC on the journal homepage. The journal is indexed in Scopus. For more information please refer to our FAQs for authors * Devoted exclusively to the study of the molecular biology, genetics, biochemistry, immunology, genome-wide association studies, pathobiology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins, interferons, new cytokines, and chemokines, Cytokine provides comprehensive coverage of cytokines and their mechanisms of actions, 12 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors. We will publish 3 major types of manuscripts: 1) Original manuscripts describing research results. 2) Basic and clinical reviews describing cytokine actions and regulation. 3) Short commentaries/perspectives on recently published aspects of cytokines, pathogenesis and clinical results. Special issues: Suggestions for special issue topics and guest editors can be sent to Jenny Henzen, [email protected]

Developmental & Comparative Immunology

ISSN: 0145-305X
5 Year impact factor: 3.1
Impact factor: 2.9

Ontogeny, Phylogeny, AgingThe Official Journal of the International Society of Developmental and Comparative Immunology Developmental and Comparative Immunology (DCI) is an international journal that publishes articles describing original research in all areas of immunology, including comparative aspects of immunity and the evolution and development of the immune system of vertebrates and invertebrates. All levels of immunological investigations are appropriate: organismal, biochemical, cellular, and molecular. The Co-Editors-in-Chief particularly encourage submission of manuscripts that address mechanistic and functional aspects of immunity.

Diagnostic Microbiology and Infectious Disease

ISSN: 0732-8893
5 Year impact factor: 2.5
Impact factor: 2.9

Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology. Diagnostic Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, immunology, immunoserology. Submissions on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed. The journal publishes topics including: Informed commentaries on new antibiotics Rapid and cost-effective methods in the laboratory Instructive case studies with emphasis on complex circumstances Insightful editorials on important current issues Book reviews that keep you up-to-date on recently published literature Laboratory and clinical management of microbial diseases Epidemiology and pathogenesis of infections Automation in the diagnostic microbiology laboratory Antibiotic susceptibility testing

European Journal of Cancer

ISSN: 0959-8049
5 Year impact factor: 8.4
Impact factor: 8.4

Official Journal of EORTC and EUSOMA The European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence. The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).

European Journal of Cancer: Supplement

ISSN: 1359-6349

EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal's websites. EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention. Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief. EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).

European Journal of Cell Biology

ISSN: 0171-9335
5 Year impact factor: 4.8
Impact factor: 6.6

Announcement: Since January 2021 the European Journal of Cell Biology became an open access journal. Authors who publish in European Journal of Cell Biology will be able to make their work immediately, permanently, and freely accessible. European Journal of Cell Biology authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright to their published work. The APC will be requested after peer review and acceptance. The APC payment will be required for all accepted articles submitted after the 30th of September 2020. The APC for European Journal of Cell Biology is USD 2100 (excluding taxes). The European Journal of Cell Biology (EJCB) welcomes articles that include original long- and short-format studies and reviews covering multi-disciplinary approaches to cell biology in models as diverse as life itself. With emphasis in quality and reproducibility, the Journal also welcomes submissions on transversal and technical advances that push the edge of knowledge forward. The fundamental aim of EJCB is to serve its audience as a platform to illuminate and communicate the inner works of cells as the basic unit of life in its many shapes and forms. Cell biology has become a multidisciplinary science driven to understand the basic principles of cellular behavior from single molecules to whole tissues and organisms. Within this scope, EJCB includes studies in the following areas and beyond: Cell-cell and cell-matrix adhesion Cell motility and migration Organelle dynamics Cell biophysics and mechanics Molecular mechanobiology Cytoskeletal dynamics Cell proliferation Cellular metabolism Signal transduction Molecular sorting Cellular differentiation and reprogramming Cellular senescence and programmed cell death Cell specialization Technical advances in cell biology In silico modelling of cell functions

European Journal of Internal Medicine

ISSN: 0953-6205
5 Year impact factor: 5.7
Impact factor: 8

The Official Journal of the European Federation of Internal Medicine (EFIM) European Journal of Internal Medicine is the official journal of the European Federation of Internal Medicine and is the reference scientific journal for the European academic and non-academic internists. The journal is devoted to promoting science and practice in internal medicine in Europe. To this end, the journal publishes original articles, editorials, reviews, internal medicine flashcards, and other information relevant to internal medicine and related fields. Translational medicine and clinical studies both receive attention by the Journal. EJIM has the ambition to become the place for the publication of excellent clinical studies; however, this target is intended to be associated with the improvement of the quality of health care in Internal Medicine in the European hospitals. The journal encourages the submission, as original articles, of: quality clinical studies related to internal medicine; papers defining the unmet clinical needs in several areas of internal medicine; methodology of clinical research and critical reading of clinical studies; high-level subgroup or secondary analyses of the major clinical trials; experimental design of planned or ongoing large clinical trials. This publication may be associated with a critical assessment by methodology experts commenting the methodology of the paper, strengths and potential limitations; acute and critical care medicine as well as emergency medicine to contribute to develop the new professional figure of the internist in the European hospitals; In addition to the abovementioned articles, the journal publishes invited articles on clinical issues relevant to internal medicine, in the form of: Commentary: a paper commenting an article published in a particular issue and prepared by the Editors or by an invited expert; Editorial: a brief article on clinical achievements or debated points in Internal Medicine; Review Articles: updated state-of-the-art reviews on a subject of clinical relevance; Ideas and Opinions: a paper on a vision concerning a clinical topic not necessarily reflecting evidence-based data but more an expression of a particular vision of a clinical or public health issue; Clinical Controversies in Internal medicine, covering pros and cons positions on a specific clinical issue; Clinical Insights: a brief article dedicated to the management of particular clinical situation or setting where remarkable advancements or changes in clinical practice were recently experienced; Beyond the guidelines on clinical situations or issues that are not covered by the Guidelines or on the limitations of the Guidelines. More in general, this type of articles can be a commentary on recently published guidelines.